Dr. Melissa Ann Carran, MD

Dr. Carran practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Carran's NPI, 1346266939, was assigned on July 15, 2006. Dr. Carran graduated from University of Cincinnati College of Medicine in 1994. Dr. Carran holds New Jersey license 25MA06934000.

Dr. Carran's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Carran's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Carran is also affiliated with Inspira Medical Center Vineland. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Carran to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carran practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Carran's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Carran is licensed in New Jersey.

CMS data shows 784 Medicare services from Dr. Carran across 8 procedure codes in 2024, for 533 Medicare patients. Medicare paid $76,931 for them.

CMS counts 533 Medicare patients who saw Dr. Carran in 2024. The largest group is under 65, with 175 patients. 74% of them have high cholesterol, and 71% have high blood pressure. 48% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carran's median patient age at 56, with 59% women.

In 2024, Dr. Carran wrote 7,976 Medicare Part D claims for 683 patients. 89% of them were for generic drugs. CMS names the drug for 7,663 of them, across 73 drugs with 11 or more claims each, at $1,037,714 in total drug cost. In 2023, CMS named 7,762 claims across 82 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Carran for performance year 2024, reported as part of a group. Dr. Carran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carran as offering telehealth.

Dmand AI links 5 papers to Dr. Carran, published from 2011 to 2017. The most frequent topics are Anticonvulsants, Electroencephalography and Epilepsy. Dr. Carran's most frequent co-authors are Umer Akbar, MD, Umang Hasmukhlal Shah, MD and Randip Singh Taneja, MD.

Dmand AI links Dr. Carran to 1 clinical trial. Conditions studied include Epilepsia Partialis Continua and Epilepsy, Partial, Motor.

CMS Open Payments shows 619 general payments to Dr. Carran from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. UCB, Inc. paid the most, $1,296.

Dr. Carran graduated from University of Cincinnati College of Medicine in 1994.